attachment
attachment
attachment
attachment
attachment
attachment

Analysis of this sperm report

Reading File
I have a clear picture of the report from the images provided. Let me now look up the WHO 2021 reference standards and do a thorough analysis.
Finding Sources
Searching the Web

WHO 2021 semen analysis reference values 6th edition normal parameters

I now have all the data I need for a thorough analysis. Here is the complete breakdown:

Semen Analysis Report - Full Analysis

Reference Standard: WHO Laboratory Manual, 6th Edition (2021)

Summary Overview

ParameterResultWHO 2021 Lower LimitStatus
Volume1.4 mL≥1.4 mLBorderline
Total Sperm Count187.6 Mil./ejaculate≥39 Mil./ejaculate✅ Normal
Sperm Concentration134 Mil./mL≥16 Mil./mL✅ Normal
Total Motility (a+b+c)51%≥42%✅ Normal
Progressive Motility (a+b)47%≥30%✅ Normal
Rapid Progressive32%≥30%✅ Normal
Normal Morphology28%≥4%✅ Normal
pH7.5>7.2✅ Normal
Liquefaction Time20 minWithin 30 min✅ Normal
Fructose TestPositivePositive✅ Normal

Detailed Parameter-by-Parameter Analysis

1. Physical Parameters

  • Volume: 1.4 mL - Right at the WHO lower limit of 1.4 mL. While technically within range, this is at the very boundary. A low ejaculate volume can reduce the total number of sperm delivered and may reflect partial retrograde ejaculation, ductal obstruction, or short abstinence. The 3-day abstinence period (within normal range) does not explain it.
  • Appearance/Viscosity/pH: All normal. Positive fructose confirms the seminal vesicles are functioning and the ejaculatory ducts are patent.

2. Sperm Count - Excellent

  • Sperm concentration: 134 million/mL - More than 8x the WHO lower limit of 16 million/mL. This is an excellent count.
  • Total sperm in ejaculate: 187.6 million - Well above the 39 million minimum. No oligospermia.

3. Motility - Normal

  • Total motility: 51% - Above the 42% cutoff. Normal.
  • Progressive motility (a+b): 47% - Well above the 30% cutoff. Normal.
  • Rapid progressive (category a): 32% - Meets the ≥30% reference. Normal.
  • Immotile sperm: 49% - Slightly above the reference of ≤20% in WHO 2021. This is notable - nearly half the sperm are non-motile, which is elevated. However, since total motility still passes the 42% threshold, this is not classified as asthenospermia.
  • Motile Progressive Sperm Concentration (MSC): 62.98 Mil/mL - Very good functional pool.
  • Sperm Motility Index (SMI): 197 - Falls in the "Good" category (>160). This composite index reflects overall motility quality.
  • Functional Sperm Concentration (FSC): 15.8 Mil/mL - This is in the "Good" range (>13 million/mL), indicating a healthy functional sperm pool.

4. Morphology - Normal (and actually quite good)

  • Normal forms: 28% - Well above the WHO minimum of 4%. This is a strong result; many men with fertility issues have morphology near the 4% cutoff.
  • Total abnormalities: 70% - This sounds alarming but is expected since ~70% abnormal is the flip side of 28-30% normal; most men have 60-80% morphologically abnormal sperm. This is within typical range.
Breakdown of abnormalities:
  • Head defects (28%): Pyriform heads (8%), acrosome defects (5%), amorphous heads (6%), round heads (4%) are the main contributors. Pyriform and amorphous heads can affect fertilization capacity.
  • Mid-piece defects (23%): Asymmetrical midpiece (6%), thin midpiece (7%), sharply bent midpiece (5%). Mid-piece defects can impair motility energy.
  • Tail defects (12%): Irregular tail (7%) is the main finding - can affect progressive movement.
  • Cytoplasmic droplets (7%): Residual cytoplasmic droplets suggest some degree of impaired sperm maturation, though mild.
  • Immature sperm (2%): Minimal, not clinically significant.

5. Auto-Agglutination: Grade 1

  • Grade 1: Isolated (<10 spermatozoa per agglutinate, many free spermatozoa). This is the mildest possible degree of agglutination. At Grade 1, it has no clinical impact on fertility. Higher grades (3-4) would suggest immunological causes.

6. Cellular Elements

  • Pus cells (1-2/HPF): Marginally elevated. Normal is <1/HPF by strict criteria. 1-2 cells is borderline and could indicate mild genital tract inflammation. Not diagnostic alone.
  • RBCs (1-2/HPF): Trace amount. Not significant on its own but worth noting - persistent blood in semen (hematospermia) should be investigated if recurrent.
  • No bacteria, fungi, Trichomonas, or casts - No evidence of infection.

Overall Impression

This is a good semen analysis overall. The key positive findings are:
  1. Excellent sperm count - 134 million/mL is far above normal
  2. Normal motility - 51% total, 47% progressive
  3. Good morphology - 28% normal forms is well above the 4% minimum
  4. Strong functional indices - SMI of 197 (Good), FSC of 15.8 (Good)
Minor concerns to be aware of:
  1. Low-borderline volume (1.4 mL) - At the absolute lower limit. A repeat test is advisable to confirm this is not a collection artifact. If consistently low, investigation for retrograde ejaculation or ejaculatory duct issues may be warranted.
  2. High immotile fraction (49%) - While total motility is technically normal (51%), nearly half the sperm not moving at all is above the WHO reference (≤20% immotile). This is worth monitoring, though not disqualifying with current fertility goals.
  3. Mid-piece and tail defects - The 23% mid-piece and 12% tail abnormalities can theoretically impair functional motility, though current motility indices compensate well.
  4. Trace pus cells - Not diagnostic of infection, but if the person is experiencing any urogenital symptoms, a culture may be worthwhile.

Clinical Interpretation

Based on WHO 6th Edition (2021) criteria, this sample does not meet criteria for oligospermia, asthenospermia, or teratospermia. For a couple trying to conceive naturally, this semen profile is generally favorable. The high sperm count and good morphology are particularly reassuring.
Note: Semen analysis is one component of fertility evaluation. A single test has natural variability; if fertility issues persist, a repeat test (ideally 2-3 weeks apart) and clinical consultation with a urologist or reproductive specialist is recommended. This analysis does not constitute medical advice.

Effect of vaping on this reports

Searching sources...
Searching PubMed

vaping e-cigarette semen parameters sperm motility morphology

Searching the Web

vaping e-cigarette effect on sperm quality male fertility 2023 2024

Searching PubMed

electronic cigarette nicotine sperm DNA fragmentation male fertility

Searching PubMed

e-cigarette male reproductive toxicity sperm

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC10053939

Here is a detailed analysis of how vaping specifically impacts each parameter from this report:

How Vaping Affects This Semen Report

E-cigarettes deliver nicotine, heavy metals (cadmium, lead), volatile aldehydes (acrolein, formaldehyde), and flavoring chemicals directly into the bloodstream. The effects on each parameter of this report are mapped below.

Parameter-by-Parameter Impact

Volume: 1.4 mL (already borderline)

Vaping makes this worse. Nicotine constricts smooth muscle in the seminal vesicles and prostate, which can reduce ejaculate volume. This result is already sitting at the WHO lower limit - vaping could push it below the threshold. Flavoring chemicals in e-liquids have also been shown to have direct glandular toxicity in animal models (PMC10053939).

Sperm Count: 134 million/mL (excellent - currently very safe)

Risk of reduction with continued vaping. A cross-sectional Danish study found daily e-cigarette users had significantly lower total sperm counts (91 million) vs. non-users (147 million). Nicotine disrupts the hypothalamic-pituitary-gonadal (HPG) axis, reduces testosterone, and directly inhibits spermatogenesis in Sertoli and Leydig cells. The current count of 134 million/mL provides a large buffer, but prolonged vaping could erode this advantage over time.

Motility - Total 51% / Progressive 47% (currently normal)

This is the most vulnerable parameter. This is where vaping does the most damage, and this report already shows a red flag - 49% immotile sperm (above the WHO upper limit for immotility). Research shows:
  • Nicotine impairs mitochondrial function in the sperm mid-piece, directly reducing ATP production needed for flagellar movement
  • The World Journal of Men's Health review (2024) confirms nicotine in any form (vaping included) reduces sperm motility
  • A 2017 British Fertility Society study found direct exposure to e-liquid flavoring caused a significant decrease in human sperm motility in cultured specimens
With continued vaping, the already-high immotile fraction (49%) is likely to increase, and total motility could drop below the 42% WHO cutoff - turning a normal result into asthenospermia.

Morphology: 28% normal (very good - currently safe)

Moderate risk with continued exposure. Animal studies show e-cigarette vapor specifically causes teratozoospermia with characteristic tail defects - looped tails, flagellar angulation, and absent flagellum. This report already shows:
  • 12% tail abnormalities (irregular tail 7%)
  • 23% mid-piece abnormalities
These exact defect types are the ones most strongly linked to e-cigarette vapor exposure. While the 28% normal forms is currently excellent, vaping selectively worsens mid-piece and tail defects - the very abnormalities already present in this report.

Immotile Sperm: 49% (already above normal)

Direct and significant concern. This is the parameter most immediately impacted by vaping. Normal is ≤20% immotile (WHO 2021). At 49%, this person is already well above that. Nicotine disrupts histone-to-protamine transition and nuclear protein integrity in sperm, which is strongly linked to reduced motility and increased immotility. The WJMH review specifically identifies this mechanism.

DNA Fragmentation (not tested here - but critical)

Vaping almost certainly increases it. This report did not include a sperm DNA fragmentation index (DFI) test. This is a significant gap. Research consistently shows:
  • E-cigarette vapor causes higher DNA damage in both testis and sperm
  • Nicotine triggers oxidative stress, which attacks sperm chromatin
  • High DNA fragmentation can cause early miscarriage even when all semen analysis parameters appear normal
Recommendation: Get a Sperm DNA Fragmentation (DFI) test done separately.

Auto-Agglutination: Grade 1 (minimal)

Vaping may worsen this indirectly. Vaping causes low-grade systemic and genital tract inflammation. Inflammation can promote anti-sperm antibody formation, which drives agglutination. The current Grade 1 is not clinically significant, but chronic inflammatory exposure from vaping could progress this over time.

Pus Cells: 1-2/HPF (borderline)

Vaping adds to this risk. Nicotine and e-cigarette chemicals increase oxidative stress and promote leukocyte infiltration into seminal fluid. The trace pus cells seen here are borderline. Continued vaping increases the chance of genital tract inflammation, which could elevate this to a clinically significant leukocytospermia (>1 million WBC/mL).

Summary Table

ParameterCurrent StatusVaping EffectRisk
Volume (1.4 mL)BorderlineReduces further⚠️ High
Sperm Count (134M/mL)ExcellentGradual reduction🟡 Moderate
Total Motility (51%)NormalDecreases motility⚠️ High
Immotile Sperm (49%)Already elevatedIncreases further🔴 Immediate
Morphology (28%)ExcellentTail/midpiece defects worsen🟡 Moderate
DNA FragmentationNot testedKnown to increase🔴 Critical gap
Auto-AgglutinationGrade 1May progress🟡 Low-moderate
Pus CellsBorderlineCan worsen🟡 Moderate

Bottom Line

This report currently shows good sperm quality but has two pre-existing vulnerabilities - borderline volume and elevated immotile fraction. Vaping specifically attacks the parameters that are already close to the edge in this report. The mechanism is mainly:
  1. Nicotine - inhibits spermatogenesis, disrupts HPG axis, impairs mitochondrial motility machinery
  2. Oxidative stress from aerosols - DNA damage, increased immotility
  3. Heavy metals and aldehydes - direct testicular toxicity, chromatin damage
  4. Flavoring chemicals - shown to reduce motility even in direct sperm exposure tests
If fertility is a goal, quitting vaping is one of the highest-yield lifestyle interventions available. Sperm has a ~74-day production cycle, meaning parameters can meaningfully improve within 2-3 months of stopping.
This analysis is educational and does not replace a consultation with a urologist or reproductive specialist.

Effect of tablet popson and capsule ubi q 300 on sperm motility

Searching sources...
Searching the Web

Popson tablet composition ingredients sperm motility male fertility

Searching the Web

UbiQ 300 capsule ubiquinol coenzyme Q10 sperm motility fertility

Searching PubMed

coenzyme Q10 ubiquinol sperm motility male infertility

Searching PubMed

L-carnitine zinc lycopene sperm motility male infertility

Reading Article

PMID: 40248985

Now I have everything needed for a thorough, evidence-based answer.

Effect of Tablet Popson & Capsule UbiQ 300 on Sperm Motility


What These Medicines Contain

Tablet Popson (by Intas Pharmaceuticals)

A combination supplement with 4 active ingredients, each targeting a different aspect of male fertility:
IngredientDose
L-Carnitine (Levocarnitine)1,000 mg
Coenzyme Q10 (Ubidecarenone)60 mg
Lycopene2,500 IU
Elemental Zinc12.5 mg

Capsule UbiQ 300

Contains Ubiquinol (the active, reduced form of CoQ10) at 300 mg - a standalone, high-dose antioxidant supplement.

How Each Ingredient Improves Sperm Motility

1. L-Carnitine (1,000 mg in Popson)

This is the most directly motility-targeted ingredient in Popson.
  • Sperm cells get nearly all their energy from fatty acid oxidation in the mid-piece mitochondria. L-carnitine is the transporter molecule that shuttles fatty acids into mitochondria.
  • Low seminal L-carnitine = reduced ATP = reduced motility. This is a well-established biochemical link.
  • Multiple RCTs show L-carnitine supplementation (1-3 g/day for 3 months) improves progressive motility, particularly in men with asthenospermia.
  • Relevance to your report: The elevated immotile fraction (49%) and mid-piece abnormalities (23%) in this report suggest mitochondrial/mid-piece dysfunction - exactly what L-carnitine addresses.

2. CoQ10 - 60 mg in Popson + 300 mg in UbiQ 300 = 360 mg total daily dose

This is where the combination becomes particularly powerful.
  • CoQ10 is naturally present in seminal plasma and sperm mid-piece mitochondria
  • It serves dual roles: energy production (electron transport chain) and antioxidant protection against reactive oxygen species (ROS)
  • ROS damage is a primary cause of immotile sperm and DNA fragmentation
  • A 2025 RCT (PMID 40248985) found ubiquinol 200 mg + zinc + D-aspartic acid significantly improved progressive sperm motility (p=0.047) and testosterone (p=0.009) over 3 months in idiopathic infertility
  • Studies using 300 mg/day CoQ10 for 26 weeks showed significant improvements in sperm motility and morphology in men with oligoasthenoteratozoospermia (OAT)
  • At 360 mg combined total (60 mg from Popson + 300 mg from UbiQ 300), this is a clinically meaningful and evidence-supported dose

3. Zinc (12.5 mg in Popson)

  • Zinc is essential for testosterone synthesis, spermatogenesis, and sperm membrane integrity
  • Zinc deficiency is directly linked to reduced motility, decreased count, and abnormal morphology
  • Zinc also has antioxidant properties, working synergistically with CoQ10 to reduce oxidative damage
  • The RCT above (PMID 40248985) included zinc alongside ubiquinol and confirmed motility benefit

4. Lycopene (2,500 IU in Popson)

  • A carotenoid antioxidant from tomatoes, with high concentration naturally found in the testis and seminal plasma
  • Reduces oxidative stress-induced sperm DNA damage
  • Some studies show lycopene supplementation improves sperm concentration and morphology
  • The network meta-analysis (PMID 37199654) confirms antioxidant combination therapy - which includes lycopene - as effective for improving sperm quality parameters

Applied Specifically to This Report

ParameterCurrent ValueExpected Benefit
Total Motility (51%)Normal but borderlineL-carnitine + CoQ10 likely to push higher, giving more buffer
Immotile sperm (49%)Elevated - main concernMost directly targeted by L-carnitine + CoQ10 (mitochondrial energy)
Progressive motility (47%)NormalCoQ10 proven to improve this specifically
Mid-piece abnormalities (23%)ElevatedL-carnitine specifically supports mid-piece function
Morphology (28% normal)Already excellentCoQ10 + lycopene protect from further oxidative morphological damage
Count (134M/mL)ExcellentZinc maintains spermatogenesis; no reduction expected
Volume (1.4 mL borderline)BorderlineThese supplements do not reduce volume; no negative effect
DNA fragmentation (not tested)UnknownCoQ10 + lycopene reduce oxidative DNA damage - likely beneficial

Timeline of Expected Effect

Sperm takes approximately 72-74 days to mature (one spermatogenic cycle). Benefits from these supplements are typically seen at:
  • 6-8 weeks: Antioxidant protection begins reducing oxidative stress on existing sperm
  • 3 months: First full cycle of supplementation-supported sperm production. Most clinical trials measure at this point and show significant motility gains
  • 6 months: Maximum benefit. Studies using 300 mg CoQ10 for 26 weeks show the strongest improvements
Both medicines should ideally be taken for a minimum of 3 months continuously before reassessing with a repeat semen analysis.

How to Take Them

  • Popson: Usually 1 tablet twice daily with food (as per prescription)
  • UbiQ 300: 1 capsule daily with a fat-containing meal (CoQ10 is fat-soluble - absorption is significantly better with food containing healthy fats)
  • Avoid taking on empty stomach, especially UbiQ 300

Bottom Line

This is a well-chosen, evidence-based combination for this specific report. The 49% immotile fraction and mid-piece abnormalities seen in the report are precisely the parameters that L-carnitine and high-dose CoQ10 are designed to address - through different but complementary mechanisms (energy substrate supply + antioxidant protection). The total 360 mg daily CoQ10 from both medicines combined is within the optimal therapeutic range supported by RCTs.
Always take these as directed by your prescribing doctor. A repeat semen analysis after 3 months is the best way to measure response.

Other ways to improve motility and reduce immotile sperm

Searching sources...
Searching PubMed

sperm motility improvement lifestyle interventions diet exercise

Searching PubMed

antioxidant supplementation asthenospermia sperm motility randomized trial

Searching the Web

evidence-based ways improve sperm motility reduce immotile sperm 2024 2025

Searching PubMed

omega-3 fatty acids selenium vitamin D sperm quality male fertility

Searching PubMed

scrotal heat testicular temperature sperm motility varicocele

Searching PubMed

omega-3 DHA sperm motility supplementation

Searching PubMed

ashwagandha male fertility sperm motility count

Searching PubMed

male infertility antioxidant supplement sperm parameters

Reading Article

PMID: 41065428

Reading Article

PMID: 36943634

Reading Article

PMID: 35506389

Excellent evidence gathered. Here is the complete, evidence-based guide:

Other Ways to Improve Sperm Motility & Reduce Immotile Sperm

Organised from highest to lowest level of evidence, and mapped to this specific report (immotile 49%, motility 51%, mid-piece defects 23%).

CATEGORY 1: Additional Supplements (Beyond Popson + UbiQ 300)

Selenium (200 mcg/day)

  • Works synergistically with CoQ10 and vitamin E. Essential for the function of glutathione peroxidase, the main antioxidant enzyme in the sperm mid-piece
  • Low selenium directly causes mid-piece structural defects - the exact abnormality pattern seen in this report (23% mid-piece abnormalities)
  • The Cochrane review on antioxidants for male subfertility (PMID 35506389) covering 90 RCTs and 10,303 men found antioxidants increased clinical pregnancy rates (OR 1.89, p<0.00001) - selenium was among the top performers

Omega-3 Fatty Acids / Fish Oil (2-3 g/day)

  • DHA (docosahexaenoic acid) is the dominant fatty acid in the sperm tail membrane. Without adequate DHA, the flagellum becomes structurally stiff and less flexible, reducing progressive motility
  • Direct incorporation into sperm membrane over one spermatogenic cycle improves fluidity and whip-like tail movement
  • Best food sources: salmon, sardines, mackerel, walnuts. Supplement: fish oil or algae-based DHA if vegetarian

Vitamin E (400 IU/day) + Vitamin C (500-1000 mg/day)

  • These water and fat-soluble antioxidants work in tandem - Vitamin E protects sperm membranes from lipid peroxidation, Vitamin C regenerates spent Vitamin E
  • Oxidative stress is a primary driver of immotile sperm - ROS attack the mitochondrial membrane of the mid-piece, stopping ATP production
  • The network meta-analysis of nutritional therapies (PMID 36943634) across 69 studies confirmed antioxidant combinations significantly improved motility and translated into higher pregnancy rates (p<0.001)

Vitamin D (2000-4000 IU/day if deficient)

  • Vitamin D receptors are present on sperm cells and in testicular tissue. Deficiency is linked to reduced sperm motility and poor morphology
  • Very common deficiency in South Asian populations - worth getting serum 25(OH)D checked. If below 30 ng/mL, supplementing is high-yield

Folic Acid + Zinc combination

  • Folic acid (5 mg/day) combined with zinc (already in Popson) was shown in earlier trials to increase sperm count by 74%. Combined zinc and folic acid supplementation also reduces DNA fragmentation
  • Note: Popson already contains zinc 12.5 mg - adding extra zinc above 40 mg/day can be counterproductive

Ashwagandha (Withania somnifera) - 600 mg/day

  • One RCT showed >150% increase in sperm count and >50% improvement in motility after 3 months
  • Acts via reducing cortisol and oxidative stress in the testes, and increasing testosterone and LH
  • Available as KSM-66 or Sensoril standardised extract

CATEGORY 2: Diet Changes

Mediterranean-Style Diet (strongest dietary evidence)

  • Rich in antioxidants, healthy fats, zinc, selenium, and folate - all directly relevant to sperm motility
  • Key foods to increase:
FoodWhat it providesSperm benefit
Walnuts (18/day)Omega-3, Vitamin EImproved motility + morphology in RCT
Fatty fish (3x/week)DHA, seleniumMid-piece integrity, tail flexibility
Leafy greensFolate, vitamin CReduces DNA fragmentation
Tomatoes/cookedLycopene (already in Popson)Antioxidant protection
Pumpkin seedsZinc, magnesiumTestosterone, spermatogenesis
EggsSelenium, vitamin D, cholineMid-piece + membrane support
Berries/citrusVitamin C, flavonoidsNeutralise ROS
Dark chocolate (85%+)Zinc, magnesium, L-arginineMotility support

Foods to Cut Back

  • Processed meats (sausages, deli meat) - trans fats directly impair sperm membrane fluidity
  • Soy-heavy diet - phytoestrogens can disrupt testosterone-to-estrogen balance
  • Excess sugar/refined carbs - causes insulin spikes and increases oxidative stress
  • Alcohol - even moderate intake reduces motility; aim for <2 standard drinks/day, ideally none

CATEGORY 3: Lifestyle Modifications (High Impact)

Heat Reduction - Most Underrated Factor

The testes need to be 2-3°C cooler than body temperature to produce motile sperm. Heat is a direct cause of increased immotile fraction.
Avoid:
  • Hot tubs, saunas, steam rooms (even 15 min raises scrotal temp for hours)
  • Laptop computers on the lap
  • Tight/synthetic underwear - switch to loose cotton boxers
  • Long periods of sitting (drivers, desk workers) - get up every 45-60 minutes
  • Heated car seats
  • Holding a phone in the front pocket consistently
Switch to: Loose-fitting trousers, cotton underwear, taking regular breaks from sitting.

Moderate Exercise (not over-training)

  • The 2026 meta-analysis on obesity interventions (PMID 41065428) found lifestyle intervention including exercise improved progressive motility by +10.56% (95% CI 8.97-12.15%) - a clinically meaningful gain
  • Optimal: 30-45 minutes of moderate aerobic exercise (brisk walking, swimming, cycling) 4-5x per week
  • Avoid: Cycling for extended periods (>60 min/session) - direct scrotal pressure and heat. Mountain biking is worse than road cycling
  • Avoid: Anabolic steroids, SARMs, testosterone replacement - these directly shut down spermatogenesis

Sleep (7-9 hours consistently)

  • Testosterone production is highest during deep sleep. Consistently sleeping less than 6 hours reduces testosterone and sperm quality
  • Sleep apnoea is directly linked to reduced sperm motility - if there is snoring or poor sleep quality, this is worth evaluating

Stress Reduction

  • Chronic psychological stress elevates cortisol, which suppresses LH and testosterone, reducing spermatogenesis
  • Cortisol also directly increases ROS in testicular tissue
  • Practical: regular exercise (already above), meditation, addressing work/relationship stressors

CATEGORY 4: Medical Investigations to Consider

Sperm DNA Fragmentation Index (DFI) Test

This is the most important missing test given the high immotile fraction. A DFI above 25% causes recurrent implantation failure even when motility looks acceptable. Many fertility specialists now recommend this before IUI/IVF.

Varicocele Screening

  • A varicocele (dilated veins in the scrotum) causes chronic heat build-up and oxidative stress, specifically targeting motility
  • Present in ~35% of men investigated for infertility
  • Grade 2-3 varicocele repair (microsurgical varicocelectomy) consistently improves motility and reduces immotile fraction within 3-6 months
  • If you haven't had a scrotal ultrasound, this is worth doing - it is a simple, painless investigation

Hormonal Evaluation

If not already done: FSH, LH, testosterone, prolactin, TSH. Abnormalities are treatable causes of poor motility:
  • Low testosterone or high FSH = primary testicular issue
  • High prolactin = can be treated with cabergoline, directly improving motility
  • Hypothyroidism = impairs spermatogenesis, easily treated

Priority Action Plan for This Report

Given the specific pattern in this report (49% immotile, mid-piece abnormalities, borderline volume), ranked in order of most likely impact:
PriorityActionTimeframe
1Stop/reduce vaping (as discussed)Immediate
2Switch to loose cotton boxers, avoid heatImmediate
3Get scrotal ultrasound to rule out varicoceleWithin 2-4 weeks
4Add Omega-3 / fish oil 2g/day + Vitamin E 400 IU + Selenium 200 mcgStart now, 3-month trial
5Mediterranean diet, cut processed foods/alcoholOngoing
6Exercise 4-5x/week moderate intensityOngoing
7Get Sperm DNA Fragmentation testWithin 1 month
8Check Vitamin D + hormone panel (FSH, testosterone, prolactin)Within 1 month
9Sleep 7-9 hours, manage stressOngoing
10Repeat semen analysis in 3 months on current regime3 months
The 74-day sperm cycle means 3 months of consistent effort is the minimum before a meaningful re-test. The combination of Popson + UbiQ 300 already covers the pharmacological base well - the additions above work through different, complementary mechanisms.
Consult a urologist or reproductive specialist for personalised evaluation, especially regarding varicocele screening and the DNA fragmentation test.
This is a shared conversation. Sign in to Orris to start your own chat.